Love Your Location

Why one of the world's leading life science companies chose Pearland

The Lonza facility in Lower Kirby. Photo courtesy of Pearland Economic Development Corp.

In 2018, Switzerland-based company Lonza debuted a 300,000-square-foot life science facility in Pearland, the largest dedicated cell and gene therapy manufacturing facility in the world at the time.

What made one of the world's largest companies for contract development and manufacturing choose Lower Kirby for this groundbreaking building?

"The location was ideal for the expansion capability, proximity to the Texas Medical Center, and ease of access from major freeways 288 and Beltway 8," says Frank Bugg, Lonza's site head. "Many Lonza employees also reside in the Pearland area."

The company also sought a location for this "Center of Excellence" that would maintain a presence on the "third coast" of biotech. Lonza currently employs more than 500 at its Pearland facility.

Additional factors that made Pearland's Lower Kirby District an attractive choice for Lonza were the nearby life sciences community, infrastructure, and quality-of-life benefits such as top-rated schools and a reasonable cost of living.

The team at this location is currently leading efforts in four categories: research and development, process development, cell and gene therapy manufacturing, and viral vector manufacturing.

Cell and gene therapy is growing and these novel medicines are getting established as a validated treatment option — the field is transforming the way cancer or genetic diseases can be treated.

In 2019, Lonza provided manufacturing services for more than 300 commercial molecules and supported the development of more than 700 pre-clinical and clinical molecules in small and large molecules, as well as supporting the launch of pioneering autologous cell therapies.

These novel drug candidates provide drastically improved patient outcomes and, in some cases, can be curative. However, manufacturing of such medicines pose complex new challenges.

Today, the cost of production still represents a major hurdle for clinical translation and commercialization of these potentially groundbreaking therapies. New technologies are needed to enable robust and cost-efficient manufacturing of high-quality medicines.

While the therapeutic opportunities for patients are exciting, the stakes for patients and drug developers are high.

Lonza serves as a partner to its customers, keeping manufacturing costs under control and following the process through the regulatory bodies through to commercialization.

The company also helps develop and commercialize its customers' innovative new therapies. Lonza scientists and engineers bring decades-long development experience across a broad spectrum of cell types and technologies. With this background, they can tailor services in process and analytical development, manufacturing, and regulatory support.

The work done at Lonza is at the forefront of medical breakthroughs. These cell and gene therapies are shaping the way we treat modern diseases, and now it's being done right in Houston's own backyard.

Since the Pearland facility's opening in 2018, Lonza has continued to expand with the addition of laboratories, clean rooms, and additional parking.

Trending News

Building Houston

 
 

Data Gumbo, founded and led by Andrew Bruce, has announced its latest funding. Photo courtesy of Data Gumbo

A Houston-based tech company has announced another round of funding to support its blockchain network growth as well as to establish a presence in the Middle East.

Data Gumbo has closed its series B funding round totaling $7.7 million with follow-on investments led by Equinor Ventures. The round includes participation from Saudi Aramco Energy Ventures and Bay Area and Houston-based venture firm L37. The round's first close was announced in September 2020 at $4 million. The additional funds to close the Series B will be used to scale Data Gumbo to serve demand for GumboNet™ and GumboNet™ ESG. Additionally, Data Gumbo plans to establish a presence in the Middle East to cover expected demand growth in the region.

"The successful close of our series B is continued proof of the efficacy and booming interest in our ability to capture critical cost savings, deliver trust and provide transparency across commercial relationships," says Andrew Bruce, founder and CEO of Data Gumbo, in a news release. "Compounded by the growing demand for transparent, accurate sustainability data and the launch of our automated ESG measurement solution, GumboNet™ ESG, Data Gumbo's trajectory is well-positioned to serve our growing customer base by ensuring economic productivity and value. This infusion of capital will support our expansion efforts as we bring more international users to our network."

With this latest raise, Data Gumbo's total funding raised to date is $18.4 million.

"Data Gumbo's success is marked by a wide variety of business use cases and opportunities for expansion," says Bruce Niven, chief investment officer at Aramco Ventures, in the release. "Our continued investment is a testament to our continued support as the company attracts new customers, experiences further demand for its network and gains traction in new markets."

The company's technology features smart contract automation and execution, which reduces contract leakage, frees up working capital, enables real-time cash and financial management, and delivers provenance with unprecedented speed, accuracy, visibility and transparency, per the release.

"Data Gumbo is the market leader for smart contracts backed by blockchain, and the coming year will be a period of exponential growth for the company as they penetrate new industrial markets," says Kemal Farid, partner at L37, in the release. "We believe strongly that GumboNet will become the de facto network for smart contracts across industries for capturing value and solving enormous pain points in contractual relations. Additionally, as companies move to meet increasing sustainability measurement demands and ESG improvements, there is a huge growth path available for Data Gumbo with the launch of GumboNet ESG."

Earlier this year, the company announced its environmental, social and corporate governance tracking and reporting tool.

"Equinor's recent pilot at the Johan Sverdrup field has demonstrated that GumboNet can create strong value for the partnership," says Gareth Burns, head of Equinor Ventures, in the release. "Our follow-on investment confirms Equinor Ventures' confidence in Data Gumbo's solution for our company and the broader energy industry."

Trending News